Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Introduction
00:00 • 2min
The Lucky Charms Podcast
01:50 • 2min
The ClSI's No Longer Recommendation for Gentamison and Pseudomonas
03:22 • 2min
The Role of Pip Tazo and Pseudomonas in Enterobacteralis
05:50 • 2min
The Role of ESBL in Resistance to Third Generation Cephalosporins
07:41 • 2min
The New Breakpoints for Ciprofloxacin and Leva Floxacin
10:03 • 2min
The Importance of PKPD
12:04 • 4min
The Evolution of PKPD Data
16:15 • 3min
The New Breakpoints for SIPRO for Enterobacteralis
19:03 • 4min
PKPD Modeling for Interbacter Alice
22:48 • 2min
The Differences Between Pseudomonas and PPP Targets
24:21 • 2min
Pseudomonas and Fluoroquinolones: New Breakpoints and Dilution
26:30 • 2min
How to Update Your Micro Lab's Panel for Ciprofloxacin
28:17 • 2min
The Importance of E-Tests in Labs
30:16 • 2min
How to Update Your Lab's Panel to Prevent Bacterial Infections
31:54 • 2min